Global Drug-Coated Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2024-2030

Global Drug-Coated Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2024-2030

Page: 90

Published Date: 24 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Drug-Coated Balloon for Coronary Artery Disease market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).

The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

This report studies the global Drug-Coated Balloon for Coronary Artery Disease production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drug-Coated Balloon for Coronary Artery Disease, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug-Coated Balloon for Coronary Artery Disease that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Drug-Coated Balloon for Coronary Artery Disease total production and demand, 2019-2030, (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease total production value, 2019-2030, (USD Million)
Global Drug-Coated Balloon for Coronary Artery Disease production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Drug-Coated Balloon for Coronary Artery Disease domestic production, consumption, key domestic manufacturers and share
Global Drug-Coated Balloon for Coronary Artery Disease production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Drug-Coated Balloon for Coronary Artery Disease market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Yinyi, Eurocor and Biotronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug-Coated Balloon for Coronary Artery Disease market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Drug-Coated Balloon for Coronary Artery Disease Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Drug-Coated Balloon for Coronary Artery Disease Market, Segmentation by Type
Paclitaxel Coated
Other Coated

Global Drug-Coated Balloon for Coronary Artery Disease Market, Segmentation by Application
Hospitals
ASCs
Catheterization Laboratory

Companies Profiled:
B. Braun
Yinyi
Eurocor
Biotronic

Key Questions Answered
1. How big is the global Drug-Coated Balloon for Coronary Artery Disease market?
2. What is the demand of the global Drug-Coated Balloon for Coronary Artery Disease market?
3. What is the year over year growth of the global Drug-Coated Balloon for Coronary Artery Disease market?
4. What is the production and production value of the global Drug-Coated Balloon for Coronary Artery Disease market?
5. Who are the key producers in the global Drug-Coated Balloon for Coronary Artery Disease market?
btl

Table of Contents

1 Supply Summary
1.1 Drug-Coated Balloon for Coronary Artery Disease Introduction
1.2 World Drug-Coated Balloon for Coronary Artery Disease Supply & Forecast
1.2.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value (2019 & 2023 & 2030)
1.2.2 World Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.2.3 World Drug-Coated Balloon for Coronary Artery Disease Pricing Trends (2019-2030)
1.3 World Drug-Coated Balloon for Coronary Artery Disease Production by Region (Based on Production Site)
1.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019-2030)
1.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2019-2030)
1.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2030)
1.3.4 North America Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.5 Europe Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.6 China Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.7 Japan Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug-Coated Balloon for Coronary Artery Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug-Coated Balloon for Coronary Artery Disease Major Market Trends

2 Demand Summary
2.1 World Drug-Coated Balloon for Coronary Artery Disease Demand (2019-2030)
2.2 World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region
2.2.1 World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region (2019-2024)
2.2.2 World Drug-Coated Balloon for Coronary Artery Disease Consumption Forecast by Region (2025-2030)
2.3 United States Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.4 China Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.5 Europe Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.6 Japan Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.7 South Korea Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.8 ASEAN Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.9 India Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)

3 World Drug-Coated Balloon for Coronary Artery Disease Manufacturers Competitive Analysis
3.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Manufacturer (2019-2024)
3.2 World Drug-Coated Balloon for Coronary Artery Disease Production by Manufacturer (2019-2024)
3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024)
3.4 Drug-Coated Balloon for Coronary Artery Disease Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug-Coated Balloon for Coronary Artery Disease Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug-Coated Balloon for Coronary Artery Disease in 2023
3.5.3 Global Concentration Ratios (CR8) for Drug-Coated Balloon for Coronary Artery Disease in 2023
3.6 Drug-Coated Balloon for Coronary Artery Disease Market: Overall Company Footprint Analysis
3.6.1 Drug-Coated Balloon for Coronary Artery Disease Market: Region Footprint
3.6.2 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
3.6.3 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison
4.1.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Comparison
4.2.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison
4.3.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.4.3 United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)
4.5 China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share
4.5.1 China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.5.3 China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)
4.6 Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)

5 Market Analysis by Type
5.1 World Drug-Coated Balloon for Coronary Artery Disease Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Paclitaxel Coated
5.2.2 Other Coated
5.3 Market Segment by Type
5.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2019-2030)
5.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2019-2030)
5.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Drug-Coated Balloon for Coronary Artery Disease Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 ASCs
6.2.3 Catheterization Laboratory
6.3 Market Segment by Application
6.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2019-2030)
6.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2019-2030)
6.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030)

7 Company Profiles
7.1 B. Braun
7.1.1 B. Braun Details
7.1.2 B. Braun Major Business
7.1.3 B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.1.4 B. Braun Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 B. Braun Recent Developments/Updates
7.1.6 B. Braun Competitive Strengths & Weaknesses
7.2 Yinyi
7.2.1 Yinyi Details
7.2.2 Yinyi Major Business
7.2.3 Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.2.4 Yinyi Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Yinyi Recent Developments/Updates
7.2.6 Yinyi Competitive Strengths & Weaknesses
7.3 Eurocor
7.3.1 Eurocor Details
7.3.2 Eurocor Major Business
7.3.3 Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.3.4 Eurocor Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Eurocor Recent Developments/Updates
7.3.6 Eurocor Competitive Strengths & Weaknesses
7.4 Biotronic
7.4.1 Biotronic Details
7.4.2 Biotronic Major Business
7.4.3 Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.4.4 Biotronic Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Biotronic Recent Developments/Updates
7.4.6 Biotronic Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Drug-Coated Balloon for Coronary Artery Disease Industry Chain
8.2 Drug-Coated Balloon for Coronary Artery Disease Upstream Analysis
8.2.1 Drug-Coated Balloon for Coronary Artery Disease Core Raw Materials
8.2.2 Main Manufacturers of Drug-Coated Balloon for Coronary Artery Disease Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Drug-Coated Balloon for Coronary Artery Disease Production Mode
8.6 Drug-Coated Balloon for Coronary Artery Disease Procurement Model
8.7 Drug-Coated Balloon for Coronary Artery Disease Industry Sales Model and Sales Channels
8.7.1 Drug-Coated Balloon for Coronary Artery Disease Sales Model
8.7.2 Drug-Coated Balloon for Coronary Artery Disease Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019-2024) & (USD Million)
Table 3. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2025-2030) & (USD Million)
Table 4. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2019-2024)
Table 5. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2025-2030)
Table 6. World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2019-2024) & (K Units)
Table 7. World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2025-2030) & (K Units)
Table 8. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2019-2024)
Table 9. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2025-2030)
Table 10. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Drug-Coated Balloon for Coronary Artery Disease Major Market Trends
Table 13. World Drug-Coated Balloon for Coronary Artery Disease Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region (2019-2024) & (K Units)
Table 15. World Drug-Coated Balloon for Coronary Artery Disease Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Drug-Coated Balloon for Coronary Artery Disease Producers in 2023
Table 18. World Drug-Coated Balloon for Coronary Artery Disease Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Drug-Coated Balloon for Coronary Artery Disease Producers in 2023
Table 20. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Drug-Coated Balloon for Coronary Artery Disease Company Evaluation Quadrant
Table 22. World Drug-Coated Balloon for Coronary Artery Disease Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Drug-Coated Balloon for Coronary Artery Disease Production Site of Key Manufacturer
Table 24. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
Table 25. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
Table 26. Drug-Coated Balloon for Coronary Artery Disease Competitive Factors
Table 27. Drug-Coated Balloon for Coronary Artery Disease New Entrant and Capacity Expansion Plans
Table 28. Drug-Coated Balloon for Coronary Artery Disease Mergers & Acquisitions Activity
Table 29. United States VS China Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Drug-Coated Balloon for Coronary Artery Disease Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 37. China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 42. Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 47. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2019-2024) & (K Units)
Table 49. World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2025-2030) & (K Units)
Table 50. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2019-2024) & (USD Million)
Table 51. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2025-2030) & (USD Million)
Table 52. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2019-2024) & (K Units)
Table 56. World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2025-2030) & (K Units)
Table 57. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2019-2024) & (USD Million)
Table 58. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2025-2030) & (USD Million)
Table 59. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2025-2030) & (US$/Unit)
Table 61. B. Braun Basic Information, Manufacturing Base and Competitors
Table 62. B. Braun Major Business
Table 63. B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 64. B. Braun Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. B. Braun Recent Developments/Updates
Table 66. B. Braun Competitive Strengths & Weaknesses
Table 67. Yinyi Basic Information, Manufacturing Base and Competitors
Table 68. Yinyi Major Business
Table 69. Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 70. Yinyi Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Yinyi Recent Developments/Updates
Table 72. Yinyi Competitive Strengths & Weaknesses
Table 73. Eurocor Basic Information, Manufacturing Base and Competitors
Table 74. Eurocor Major Business
Table 75. Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 76. Eurocor Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eurocor Recent Developments/Updates
Table 78. Biotronic Basic Information, Manufacturing Base and Competitors
Table 79. Biotronic Major Business
Table 80. Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 81. Biotronic Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Global Key Players of Drug-Coated Balloon for Coronary Artery Disease Upstream (Raw Materials)
Table 83. Drug-Coated Balloon for Coronary Artery Disease Typical Customers
Table 84. Drug-Coated Balloon for Coronary Artery Disease Typical Distributors
List of Figure
Figure 1. Drug-Coated Balloon for Coronary Artery Disease Picture
Figure 2. World Drug-Coated Balloon for Coronary Artery Disease Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Drug-Coated Balloon for Coronary Artery Disease Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 5. World Drug-Coated Balloon for Coronary Artery Disease Average Price (2019-2030) & (US$/Unit)
Figure 6. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2019-2030)
Figure 7. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2019-2030)
Figure 8. North America Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 9. Europe Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 10. China Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 11. Japan Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 12. Drug-Coated Balloon for Coronary Artery Disease Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 15. World Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share by Region (2019-2030)
Figure 16. United States Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 17. China Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 18. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 19. Japan Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 20. South Korea Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 22. India Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Drug-Coated Balloon for Coronary Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug-Coated Balloon for Coronary Artery Disease Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug-Coated Balloon for Coronary Artery Disease Markets in 2023
Figure 26. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 30. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 32. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Type in 2023
Figure 34. Paclitaxel Coated
Figure 35. Other Coated
Figure 36. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Type (2019-2030)
Figure 37. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Type (2019-2030)
Figure 38. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Application in 2023
Figure 41. Hospitals
Figure 42. ASCs
Figure 43. Catheterization Laboratory
Figure 44. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Application (2019-2030)
Figure 45. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Application (2019-2030)
Figure 46. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Drug-Coated Balloon for Coronary Artery Disease Industry Chain
Figure 48. Drug-Coated Balloon for Coronary Artery Disease Procurement Model
Figure 49. Drug-Coated Balloon for Coronary Artery Disease Sales Model
Figure 50. Drug-Coated Balloon for Coronary Artery Disease Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

B. Braun
Yinyi
Eurocor
Biotronic
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Drug-Coated Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2024-2030

Global Drug-Coated Balloon for Coronary Artery Disease Supply, Demand and Key Producers, 2024-2030

Page: 90

Published Date: 24 Feb 2024

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Drug-Coated Balloon for Coronary Artery Disease market size is expected to reach $ 1216 million by 2030, rising at a market growth of 15.1% CAGR during the forecast period (2024-2030).

The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.

The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.

This report studies the global Drug-Coated Balloon for Coronary Artery Disease production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Drug-Coated Balloon for Coronary Artery Disease, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug-Coated Balloon for Coronary Artery Disease that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Drug-Coated Balloon for Coronary Artery Disease total production and demand, 2019-2030, (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease total production value, 2019-2030, (USD Million)
Global Drug-Coated Balloon for Coronary Artery Disease production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Drug-Coated Balloon for Coronary Artery Disease domestic production, consumption, key domestic manufacturers and share
Global Drug-Coated Balloon for Coronary Artery Disease production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Drug-Coated Balloon for Coronary Artery Disease production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Drug-Coated Balloon for Coronary Artery Disease market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun, Yinyi, Eurocor and Biotronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug-Coated Balloon for Coronary Artery Disease market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Drug-Coated Balloon for Coronary Artery Disease Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Drug-Coated Balloon for Coronary Artery Disease Market, Segmentation by Type
Paclitaxel Coated
Other Coated

Global Drug-Coated Balloon for Coronary Artery Disease Market, Segmentation by Application
Hospitals
ASCs
Catheterization Laboratory

Companies Profiled:
B. Braun
Yinyi
Eurocor
Biotronic

Key Questions Answered
1. How big is the global Drug-Coated Balloon for Coronary Artery Disease market?
2. What is the demand of the global Drug-Coated Balloon for Coronary Artery Disease market?
3. What is the year over year growth of the global Drug-Coated Balloon for Coronary Artery Disease market?
4. What is the production and production value of the global Drug-Coated Balloon for Coronary Artery Disease market?
5. Who are the key producers in the global Drug-Coated Balloon for Coronary Artery Disease market?
btl

Table of Contents

1 Supply Summary
1.1 Drug-Coated Balloon for Coronary Artery Disease Introduction
1.2 World Drug-Coated Balloon for Coronary Artery Disease Supply & Forecast
1.2.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value (2019 & 2023 & 2030)
1.2.2 World Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.2.3 World Drug-Coated Balloon for Coronary Artery Disease Pricing Trends (2019-2030)
1.3 World Drug-Coated Balloon for Coronary Artery Disease Production by Region (Based on Production Site)
1.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019-2030)
1.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2019-2030)
1.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2030)
1.3.4 North America Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.5 Europe Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.6 China Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.3.7 Japan Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug-Coated Balloon for Coronary Artery Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug-Coated Balloon for Coronary Artery Disease Major Market Trends

2 Demand Summary
2.1 World Drug-Coated Balloon for Coronary Artery Disease Demand (2019-2030)
2.2 World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region
2.2.1 World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region (2019-2024)
2.2.2 World Drug-Coated Balloon for Coronary Artery Disease Consumption Forecast by Region (2025-2030)
2.3 United States Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.4 China Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.5 Europe Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.6 Japan Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.7 South Korea Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.8 ASEAN Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)
2.9 India Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030)

3 World Drug-Coated Balloon for Coronary Artery Disease Manufacturers Competitive Analysis
3.1 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Manufacturer (2019-2024)
3.2 World Drug-Coated Balloon for Coronary Artery Disease Production by Manufacturer (2019-2024)
3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024)
3.4 Drug-Coated Balloon for Coronary Artery Disease Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drug-Coated Balloon for Coronary Artery Disease Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drug-Coated Balloon for Coronary Artery Disease in 2023
3.5.3 Global Concentration Ratios (CR8) for Drug-Coated Balloon for Coronary Artery Disease in 2023
3.6 Drug-Coated Balloon for Coronary Artery Disease Market: Overall Company Footprint Analysis
3.6.1 Drug-Coated Balloon for Coronary Artery Disease Market: Region Footprint
3.6.2 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
3.6.3 Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison
4.1.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Comparison
4.2.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison
4.3.1 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.4.3 United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)
4.5 China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share
4.5.1 China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.5.3 China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)
4.6 Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024)

5 Market Analysis by Type
5.1 World Drug-Coated Balloon for Coronary Artery Disease Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Paclitaxel Coated
5.2.2 Other Coated
5.3 Market Segment by Type
5.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2019-2030)
5.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2019-2030)
5.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Drug-Coated Balloon for Coronary Artery Disease Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospitals
6.2.2 ASCs
6.2.3 Catheterization Laboratory
6.3 Market Segment by Application
6.3.1 World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2019-2030)
6.3.2 World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2019-2030)
6.3.3 World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030)

7 Company Profiles
7.1 B. Braun
7.1.1 B. Braun Details
7.1.2 B. Braun Major Business
7.1.3 B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.1.4 B. Braun Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 B. Braun Recent Developments/Updates
7.1.6 B. Braun Competitive Strengths & Weaknesses
7.2 Yinyi
7.2.1 Yinyi Details
7.2.2 Yinyi Major Business
7.2.3 Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.2.4 Yinyi Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Yinyi Recent Developments/Updates
7.2.6 Yinyi Competitive Strengths & Weaknesses
7.3 Eurocor
7.3.1 Eurocor Details
7.3.2 Eurocor Major Business
7.3.3 Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.3.4 Eurocor Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Eurocor Recent Developments/Updates
7.3.6 Eurocor Competitive Strengths & Weaknesses
7.4 Biotronic
7.4.1 Biotronic Details
7.4.2 Biotronic Major Business
7.4.3 Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
7.4.4 Biotronic Drug-Coated Balloon for Coronary Artery Disease Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Biotronic Recent Developments/Updates
7.4.6 Biotronic Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Drug-Coated Balloon for Coronary Artery Disease Industry Chain
8.2 Drug-Coated Balloon for Coronary Artery Disease Upstream Analysis
8.2.1 Drug-Coated Balloon for Coronary Artery Disease Core Raw Materials
8.2.2 Main Manufacturers of Drug-Coated Balloon for Coronary Artery Disease Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Drug-Coated Balloon for Coronary Artery Disease Production Mode
8.6 Drug-Coated Balloon for Coronary Artery Disease Procurement Model
8.7 Drug-Coated Balloon for Coronary Artery Disease Industry Sales Model and Sales Channels
8.7.1 Drug-Coated Balloon for Coronary Artery Disease Sales Model
8.7.2 Drug-Coated Balloon for Coronary Artery Disease Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2019-2024) & (USD Million)
Table 3. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Region (2025-2030) & (USD Million)
Table 4. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2019-2024)
Table 5. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2025-2030)
Table 6. World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2019-2024) & (K Units)
Table 7. World Drug-Coated Balloon for Coronary Artery Disease Production by Region (2025-2030) & (K Units)
Table 8. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2019-2024)
Table 9. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2025-2030)
Table 10. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Drug-Coated Balloon for Coronary Artery Disease Major Market Trends
Table 13. World Drug-Coated Balloon for Coronary Artery Disease Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Drug-Coated Balloon for Coronary Artery Disease Consumption by Region (2019-2024) & (K Units)
Table 15. World Drug-Coated Balloon for Coronary Artery Disease Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Drug-Coated Balloon for Coronary Artery Disease Producers in 2023
Table 18. World Drug-Coated Balloon for Coronary Artery Disease Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Drug-Coated Balloon for Coronary Artery Disease Producers in 2023
Table 20. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Drug-Coated Balloon for Coronary Artery Disease Company Evaluation Quadrant
Table 22. World Drug-Coated Balloon for Coronary Artery Disease Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Drug-Coated Balloon for Coronary Artery Disease Production Site of Key Manufacturer
Table 24. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Type Footprint
Table 25. Drug-Coated Balloon for Coronary Artery Disease Market: Company Product Application Footprint
Table 26. Drug-Coated Balloon for Coronary Artery Disease Competitive Factors
Table 27. Drug-Coated Balloon for Coronary Artery Disease New Entrant and Capacity Expansion Plans
Table 28. Drug-Coated Balloon for Coronary Artery Disease Mergers & Acquisitions Activity
Table 29. United States VS China Drug-Coated Balloon for Coronary Artery Disease Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Drug-Coated Balloon for Coronary Artery Disease Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Drug-Coated Balloon for Coronary Artery Disease Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 37. China Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 42. Rest of World Based Drug-Coated Balloon for Coronary Artery Disease Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share (2019-2024)
Table 47. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2019-2024) & (K Units)
Table 49. World Drug-Coated Balloon for Coronary Artery Disease Production by Type (2025-2030) & (K Units)
Table 50. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2019-2024) & (USD Million)
Table 51. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type (2025-2030) & (USD Million)
Table 52. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2019-2024) & (K Units)
Table 56. World Drug-Coated Balloon for Coronary Artery Disease Production by Application (2025-2030) & (K Units)
Table 57. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2019-2024) & (USD Million)
Table 58. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application (2025-2030) & (USD Million)
Table 59. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2025-2030) & (US$/Unit)
Table 61. B. Braun Basic Information, Manufacturing Base and Competitors
Table 62. B. Braun Major Business
Table 63. B. Braun Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 64. B. Braun Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. B. Braun Recent Developments/Updates
Table 66. B. Braun Competitive Strengths & Weaknesses
Table 67. Yinyi Basic Information, Manufacturing Base and Competitors
Table 68. Yinyi Major Business
Table 69. Yinyi Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 70. Yinyi Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Yinyi Recent Developments/Updates
Table 72. Yinyi Competitive Strengths & Weaknesses
Table 73. Eurocor Basic Information, Manufacturing Base and Competitors
Table 74. Eurocor Major Business
Table 75. Eurocor Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 76. Eurocor Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eurocor Recent Developments/Updates
Table 78. Biotronic Basic Information, Manufacturing Base and Competitors
Table 79. Biotronic Major Business
Table 80. Biotronic Drug-Coated Balloon for Coronary Artery Disease Product and Services
Table 81. Biotronic Drug-Coated Balloon for Coronary Artery Disease Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Global Key Players of Drug-Coated Balloon for Coronary Artery Disease Upstream (Raw Materials)
Table 83. Drug-Coated Balloon for Coronary Artery Disease Typical Customers
Table 84. Drug-Coated Balloon for Coronary Artery Disease Typical Distributors
List of Figure
Figure 1. Drug-Coated Balloon for Coronary Artery Disease Picture
Figure 2. World Drug-Coated Balloon for Coronary Artery Disease Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Drug-Coated Balloon for Coronary Artery Disease Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 5. World Drug-Coated Balloon for Coronary Artery Disease Average Price (2019-2030) & (US$/Unit)
Figure 6. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Region (2019-2030)
Figure 7. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Region (2019-2030)
Figure 8. North America Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 9. Europe Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 10. China Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 11. Japan Drug-Coated Balloon for Coronary Artery Disease Production (2019-2030) & (K Units)
Figure 12. Drug-Coated Balloon for Coronary Artery Disease Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 15. World Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share by Region (2019-2030)
Figure 16. United States Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 17. China Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 18. Europe Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 19. Japan Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 20. South Korea Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 22. India Drug-Coated Balloon for Coronary Artery Disease Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Drug-Coated Balloon for Coronary Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Drug-Coated Balloon for Coronary Artery Disease Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Drug-Coated Balloon for Coronary Artery Disease Markets in 2023
Figure 26. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Drug-Coated Balloon for Coronary Artery Disease Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 30. China Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Drug-Coated Balloon for Coronary Artery Disease Production Market Share 2023
Figure 32. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Type in 2023
Figure 34. Paclitaxel Coated
Figure 35. Other Coated
Figure 36. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Type (2019-2030)
Figure 37. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Type (2019-2030)
Figure 38. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Drug-Coated Balloon for Coronary Artery Disease Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Application in 2023
Figure 41. Hospitals
Figure 42. ASCs
Figure 43. Catheterization Laboratory
Figure 44. World Drug-Coated Balloon for Coronary Artery Disease Production Market Share by Application (2019-2030)
Figure 45. World Drug-Coated Balloon for Coronary Artery Disease Production Value Market Share by Application (2019-2030)
Figure 46. World Drug-Coated Balloon for Coronary Artery Disease Average Price by Application (2019-2030) & (US$/Unit)
Figure 47. Drug-Coated Balloon for Coronary Artery Disease Industry Chain
Figure 48. Drug-Coated Balloon for Coronary Artery Disease Procurement Model
Figure 49. Drug-Coated Balloon for Coronary Artery Disease Sales Model
Figure 50. Drug-Coated Balloon for Coronary Artery Disease Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

B. Braun
Yinyi
Eurocor
Biotronic
jiaGou

Add To Cart

gouMai

Buy Now